Nu Skin Enterprises, Inc.
NUS
$6.55
-$0.08-1.21%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -13.42% | 1.68% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -13.42% | 1.68% | |||
| Cost of Revenue | -2.03% | 0.79% | |||
| Gross Profit | -18.14% | 2.05% | |||
| SG&A Expenses | -12.62% | 1.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.32% | 1.32% | |||
| Operating Income | -74.77% | 7.40% | |||
| Income Before Tax | -85.71% | 13.74% | |||
| Income Tax Expenses | -79.38% | 441.01% | |||
| Earnings from Continuing Operations | -87.33% | -15.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -87.33% | -15.15% | |||
| EBIT | -74.77% | 7.40% | |||
| EBITDA | -49.64% | 7.18% | |||
| EPS Basic | -87.23% | -13.71% | |||
| Normalized Basic EPS | 145.20% | -122.81% | |||
| EPS Diluted | -86.41% | -17.53% | |||
| Normalized Diluted EPS | 145.32% | -122.61% | |||
| Average Basic Shares Outstanding | -0.78% | -1.65% | |||
| Average Diluted Shares Outstanding | -0.98% | -0.79% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 6.80% | 0.16% | |||